STAGE I LUNG CANCER AJCC V8
Clinical trials for STAGE I LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug stop lung cancer before it starts?
Prevention CompletedThis study tested whether the immunotherapy drug pembrolizumab could prevent lung cancer from coming back in 45 people with early-stage lung cancer or high-risk lung nodules. Participants received the drug and were monitored for tumor response and survival. The goal was to see if…
Matched conditions: STAGE I LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 15, 2026 18:57 UTC
-
Heart monitors reveal hidden risks after cancer radiation
Knowledge-focused CompletedThis study looked at heart changes in 24 people receiving radiation or chemo-radiation for lung or esophageal cancer that hadn't spread. Participants got a small heart monitor implanted to track heart problems that might otherwise go unnoticed. The goal was to better understand a…
Matched conditions: STAGE I LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 17, 2026 00:41 UTC